Championing balance, creativity, and intentional routines through modern cannabis digital art experiences New Jersey, US, 25th February 2026, ZEX PR WIRE, As conversations around wellness, creativity, […]
Read moreCMS (867.HK/8A8.SG): NDA for Additional Indication Atopic Dermatitis (AD) for Ruxolitinib Phosphate Cream Accepted and Granted Priority Review in China
SHENZHEN, CHINA – China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the […]
Read more